NASDAQ:HOOK • US43906K2096
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HOOKIPA PHARMA INC (HOOK).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-01-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-12-20 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-11-21 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-11-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-26 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-06-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-04-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-27 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-06 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-30 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-06-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-20 | Truist Securities | Maintains | Buy |
| 2023-03-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-02 | B of A Securities | Downgrade | Buy -> Underperform |
| 2022-11-15 | RBC Capital | Maintains | Outperform |
| 2022-08-23 | Truist Securities | Maintains | Buy |
| 2022-08-11 | SVB Leerink | Maintains | Outperform |
| 2022-02-17 | HC Wainwright & Co. | Maintains | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.25M -22.76% | 20.129M 41.26% | 43.946M 118.32% | 25.5M -41.97% | 1.02M -96.00% | 10.2M 900.00% | 20.4M 100.00% | 20.4M | 20.4M | 20.4M | 10.2M -50.00% | |
| EBITDA YoY % growth | -69.56M 9.70% | -81.376M -16.99% | -42.034M 48.35% | -87.006M -106.99% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -73.16M 10.42% | -84.928M -16.09% | -44.787M 47.26% | -74.824M -67.07% | -87.646M -17.14% | -86.834M 0.93% | -102.276M -17.78% | -129.931M -27.04% | -159.386M -22.67% | -180.405M -13.19% | -192.135M -6.50% | |
| Operating Margin | -513.40% | -421.92% | -101.91% | -293.43% | -8,592.70% | -851.31% | -501.36% | -636.92% | -781.31% | -884.34% | -1,883.68% | |
| EPS YoY % growth | -10.50 54.55% | -8.80 16.19% | -3.51 60.11% | -2.65 24.44% | -1.59 40.00% | -1.28 19.87% | -1.40 -9.60% | -1.79 -27.74% | -2.19 -22.86% | -2.50 -13.95% | -2.68 -7.35% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.62 59.07% | -0.20 81.45% | -0.20 89.75% |
| Revenue Q2Q % growth | 3.443M 166.90% | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.653M 56.91% | N/A | N/A |
All data in USD
7 analysts have analysed HOOK and the average price target is 29.07 USD. This implies a price increase of 3359.48% is expected in the next year compared to the current price of 0.8403.
HOOKIPA PHARMA INC (HOOK) will report earnings on 2025-11-12.
The consensus EPS estimate for the next earnings of HOOKIPA PHARMA INC (HOOK) is -0.62 USD and the consensus revenue estimate is 3.44M USD.
The number of analysts covering HOOKIPA PHARMA INC (HOOK) is 7.